Leone Patterson
Förmögenhet: 11 998 $ per 2026-06-30
Förmögenhet: 11 998 $ per 2026-06-30
Leone D.
Patterson currently serves as Independent Director at Nkarta, Inc. since 2020, Independent Director at Kalaris Therapeutics, Inc. starting in 2025, and Executive VP, Chief Business & Financial Officer at Zymeworks BC, Inc. beginning in 2024.
Former roles include Independent Non-Executive Director at Oxford Biomedica Plc from 2023 to 2024, Independent Director at Climb Bio, Inc. from 2021 to 2024, Vice President & Corporate Controller at Chiron Corp.
from 1999 to 2006, Vice President-Finance at Exelixis, Inc. from 2007 to 2010, Senior Manager at KPMG LLP from 1989 to 1999, VP-Global Business Planning & Analysis at Novartis AG from 2006 to 2007, Vice President & Global Corporate Controller at NetApp, Inc. from 2010 to 2012, Chief Financial Officer & Vice President at Transcept Pharma, Inc. from 2012 to 2014, Chief Financial Officer at Diadexus, Inc. from 2015 to 2016, President, Chief Financial & Accounting Officer at Adverum Biotechnologies, Inc. in 2021, Executive VP, Chief Financial & Business Officer at Zymeworks, Inc. from 2024 to 2026, and Chief Financial & Business Officer at Tenaya Therapeutics, Inc. from 2021 to 2024.
Education includes undergraduate studies at Chapman University and an MBA from St. Mary's College (Indiana) conferred in 2008.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-06 | 459 ( 0 % ) | 11 998 $ | 2026-06-30 | |
-.--% | 2026-06-03 | 0 ( -.--% ) | - $ | 2026-06-30 |
NKARTA, INC. -.--% | 2026-06-10 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| NKARTA, INC. | Direktör/Styrelseledamot | 2020-04-27 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Finansdirektör/CFO | 2024-09-01 |
| Företag | Position | Slut |
|---|---|---|
| ZYMEWORKS INC. | Finansdirektör/CFO | 2026-01-07 |
| OXFORD BIOMEDICA PLC | Direktör/Styrelseledamot | 2024-12-31 |
| CLIMB BIO, INC. | Direktör/Styrelseledamot | 2024-12-01 |
| TENAYA THERAPEUTICS, INC. | Finansdirektör/CFO | 2024-08-14 |
| ADVERUM BIOTECHNOLOGIES, INC. | Verkställande Direktör | 2020-06-15 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 16 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Chapman University
Chapman University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Mary's College (Indiana)
St. Mary's College (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NetApp, Inc.
NetApp, Inc. Computer PeripheralsElectronic Technology Provides data management and storage solutions | Electronic Technology |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Diadexus, Inc.
Diadexus, Inc. Medical SpecialtiesHealth Technology Develops and commercializes patent-protected in vitro diagnostic products | Health Technology |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Nkarta, Inc.
Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Zymeworks, Inc.
Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån